Protagonist Therapeutics, Inc. (PTGX)

NASDAQ: PTGX · Real-Time Price · USD

92.08

+3.69 (4.17%)

At close: Feb 27, 2026, 4:00 PM EST

92.09

+0.01 (0.01%)

After-hours: Feb 27, 2026, 5:48 PM EST

Protagonist Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	46.02	434.43	60	26.58	27.36
Revenue Growth (YoY)	-89.41%	624.05%	125.72%	-2.84%	-4.44%
Gross Profit	46.02	434.43	60	26.58	27.36
Selling, General & Admin	44.85	43.46	33.49	31.74	27.2
Research & Development	159.29	138.13	120.16	126.22	126.01
Operating Expenses	204.14	181.59	153.65	157.95	153.2
Operating Income	-158.13	252.84	-93.65	-131.37	-125.85
Interest & Investment Income	28.79	26.32	14.9	4.06	0.44
Currency Exchange Gain (Loss)	-	-	-	-0.08	-0.15
Other Non Operating Income (Expenses)	0.03	0.25	-0.2	-	-
EBT Excluding Unusual Items	-129.31	279.41	-78.96	-127.39	-125.55
Pretax Income	-129.31	279.41	-78.96	-127.39	-125.55
Income Tax Expense	0.84	4.22	-	-	-
Net Income	-130.15	275.19	-78.96	-127.39	-125.55
Net Income to Common	-130.15	275.19	-78.96	-127.39	-125.55
Shares Outstanding (Basic)	64	62	57	49	46
Shares Outstanding (Diluted)	64	65	57	49	46
Shares Change (YoY)	-2.31%	14.65%	15.74%	5.87%	34.67%
EPS (Basic)	-2.05	4.47	-1.39	-2.60	-2.71
EPS (Diluted)	-2.05	4.23	-1.39	-2.60	-2.71
Free Cash Flow	56.08	182.8	-70.85	-108.93	-108.97
Free Cash Flow Per Share	0.88	2.81	-1.25	-2.22	-2.35
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-343.63%	58.20%	-156.09%	-494.24%	-460.01%
Profit Margin	-282.83%	63.34%	-131.59%	-479.26%	-458.94%
Free Cash Flow Margin	121.87%	42.08%	-118.08%	-409.81%	-398.31%
EBITDA	-156.85	253.67	-92.68	-130.34	-125.03
EBITDA Margin	-	58.39%	-154.46%	-	-
D&A For EBITDA	1.28	0.83	0.98	1.03	0.81
EBIT	-158.13	252.84	-93.65	-131.37	-125.85
EBIT Margin	-	58.20%	-156.09%	-	-
Effective Tax Rate	-	1.51%	-	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q